{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:59:32Z","timestamp":1780646372641,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GR 972\/47-2"],"award-info":[{"award-number":["GR 972\/47-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA 1648\/12-2"],"award-info":[{"award-number":["MA 1648\/12-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijpddr.2021.05.008","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T12:42:02Z","timestamp":1622551322000},"page":"148-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-7800","authenticated-orcid":false,"given":"Johanna","family":"Zech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Dzikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Simantov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Golenser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1613-6976","authenticated-orcid":false,"given":"Karsten","family":"M\u00e4der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2021.05.008_bib1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11095-018-2471-9","article-title":"Formulation of natural oil nano-emulsions for the topical delivery of clofazimine, artemisone and decoquinate","volume":"35","author":"Burger","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2353\/ajpath.2010.090691","article-title":"Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine","volume":"176","author":"Cabrales","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.02.041","article-title":"In vitro skin permeation of artemisone and its nano-vesicular formulations","volume":"503","author":"Dwivedi","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13071-017-2018-7","article-title":"Controlled release of artemisone for the treatment of experimental cerebral malaria","volume":"10","author":"Golenser","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2021.05.008_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00846","article-title":"Treatment of experimental cerebral malaria by slow release of artemisone from injectable pasty formulation","volume":"11","author":"Golenser","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.16930","article-title":"Artemether for topical use in patients with seborrhoeic keratosis","volume":"179","author":"H\u00e4rtel","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib7","series-title":"Product Monograph EVRA\u00ae Transdermal System","year":"2008"},{"key":"10.1016\/j.ijpddr.2021.05.008_bib8","series-title":"Prescribing Information DURAGESIC\u00ae (Fentanyl Transdermal System","year":"2019"},{"key":"10.1016\/j.ijpddr.2021.05.008_bib9","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1128\/AAC.00482-15","article-title":"Altering antimalarial drug regimens may dramatically enhance and restore drug effectiveness","volume":"59","author":"Kay","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4269\/ajtmh.1991.45.602","article-title":"Transdermal artelinic acid: an effective treatment for Plasmodium berghei- infected mice","volume":"45","author":"Klayman","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.trstmh.2006.04.010","article-title":"Toxicity evaluation of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats","volume":"101","author":"Li","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.intimp.2011.11.004","article-title":"Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity","volume":"12","author":"Li","year":"2012","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4269\/ajtmh.1994.50.777","article-title":"Antimalarial activity of dihydroartemisinin derivatives by transdermal application","volume":"50","author":"Lin","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0020-7519(98)00088-5","article-title":"Rodent malaria prophylaxis by transdermal delivery of primaquine","volume":"28","author":"Mayorga","year":"1998","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib15","first-page":"1","article-title":"Geographic expansion of artemisinin resistance","volume":"26","author":"M\u00fcller","year":"2019","journal-title":"J. Trav. Med."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib16","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1128\/AAC.01585-07","article-title":"First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone","volume":"52","author":"Nagelschmitz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijpharm.2014.10.004","article-title":"Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application","volume":"477","author":"Nnamani","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib18","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1128\/AAC.00471-09","article-title":"Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum","volume":"53","author":"Obaldia","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib19","article-title":"Mouse models of innate immunity: methods and protocols","author":"Oca","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib20","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1128\/AAC.00488-13","article-title":"Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria","volume":"57","author":"Orjuela-S\u00e1nchez","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113193","article-title":"Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research","author":"Patel","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-1942-5","article-title":"Challenges to replace ACT as first-line drug","volume":"16","author":"Phyo","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib23","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/AAC.05013-14","article-title":"Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in healthy adults","volume":"59","author":"Salman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib24","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.2147\/IJN.S83402","article-title":"Compound antimalarial ethosomal cataplasm: preparation, evaluation, and mechanism of penetration enhancement","volume":"10","author":"Shen","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167132","article-title":"The effects of transdermally delivered oleanolic acid on malaria parasites and blood glucose homeostasis in P. Berghei-infected male Sprague-Dawley rats","volume":"11","author":"Sibiya","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2021.05.008_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2011.05.003","article-title":"Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of PheroidTM technology","volume":"414","author":"Steyn","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pt.2019.09.005","article-title":"Artemisinin bioactivity and resistance in malaria parasites","author":"Talman","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1208\/s12249-018-1251-5","article-title":"Topical delivery of artemisone, clofazimine and decoquinate encapsulated in vesicles and their in vitro efficacy against Mycobacterium tuberculosis","volume":"20","author":"van Zyl","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpddr.2021.05.008_bib29","doi-asserted-by":"crossref","first-page":"e72722","DOI":"10.1371\/journal.pone.0072722","article-title":"Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria","volume":"8","author":"Waknine-Grinberg","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2021.05.008_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-9-227","article-title":"Artemisone effective against murine cerebral malaria","volume":"9","author":"Waknine-Grinberg","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib31","series-title":"Emergence and Spread of Artemisinin Resistance Calls for Intensified Efforts to Withdraw Oral Artemisinin-Based Monotherapy from the Market","first-page":"1","author":"WHO Global Malaria Programme","year":"2014"},{"key":"10.1016\/j.ijpddr.2021.05.008_bib32","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3389\/fphar.2020.558894","article-title":"Anti-melanoma activities of artemisone and prenylated amino-artemisinins in combination with known anticancer drugs","volume":"11","author":"Wong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpddr.2021.05.008_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12060509","article-title":"Oral administration of artemisone for the treatment of schistosomiasis: formulation challenges and in vivo efficacy","volume":"12","author":"Zech","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpddr.2021.05.008_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02106-20","article-title":"Efficient treatment of experimental cerebral malaria by an artemisone-SMEDDS system: impact of application route and dosing frequency","volume":"65","author":"Zech","year":"2021","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:40:29Z","timestamp":1778845229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320721000270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":34,"alternative-id":["S2211320721000270"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.05.008","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}